Categories: Latest

International Fertility Lubricant Company, Receives Patent For ‘Conceive Plus’ In India

Sasmar, An International Fertility Lubricant Company, Receives Patent For ‘Conceive Plus’ In India

Brussels, May 29, 2017: Sasmar Pharmaceuticals, a multi-national lubricant design, development, and manufacturing company that specializes in the creation of personal lubricants, fertility lubricants, and lubricant-related products, this week excitedly announced the revolutionary product Conceive Plus, a sperm-friendly fertility lubricant for all trying-to-conceive couples, has been awarded patent no. 278692 by the Indian Patent Office.

As a United States FDA-cleared fertility lubricant that is formulated to be isotonic and meet a pH range compatible with human sperm survival and migration, Conceive Plus is a family-trusted personal lubricant that is taking the world by storm today.

Conceive Plus is the only fertility lubricant that contains Calcium and Magnesium ions to support fertility and the process of conception ,” said John-Michael Mancini Founder and Owner of SASMAR.
“Its unique formula helps users increase pleasure while relieving the negative side effects of sexual dryness. We are incredibly excited that this revolutionary product has now been awarded patent protection in India in addition to the other countries it is readily available.”

The unique composition of Conceive Plus has resulted in studies showing that there were greater than 99% viable human sperm after two hours exposure to the product. Additionally, the product increases the likelihood of conception by assisting sperm migration and bonding of sperm to egg.

With the arrival of the Indian patent, Conceive Plus is now ready for entry on the market in India and the company is now seeking distribution partnerships. “Our goal is to have Conceive Plus available in all pharmacies in India, providing access to this product to all couples in the entire country” said Emmanuelle Gibault-Nowak, Business Development Manager.

“Right now, Conceive Plus is being used in hospitals, fertility clinics, or directly by couples that have just made the incredible decision to have a baby,” said Mancini. “This product is commercialized in over 70 countries around the world today, and we are ecstatic to be adding India to the list.”

Conceive Plus does not negatively impact human sperm function or harm human sperm DNA.
For more information on Conceive Plus fertility lubricant, visit: http://www.conceiveplus.com/what-is-conceive-plus

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

1 day ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago